Jump to contentJump to search

CRC 1116 "Master switches in cardiac ischemia"

CRC 1116 "Master switches in cardiac ischemia"

The fundamental and prospective aim of the CRC 1116 “Master switches in cardiac ischemia” is to identify new targets, i.e. molecules, pathways and mechanisms that are critical for the acute and subacute response to myocardial ischemia, which we define as “master switches”. Importantly, the CRC 1116 considers systemic cross talk of ischemic cardiac injury and systemic inflammatory responses, metabolic comorbidities (obesity, insulin resistance, type 2 diabetes (T2DM)) and anemia.

 

  • Prof. Dr. rer. nat. Jens Fischer
  • +49 211 81-12500
  • +49 211 81-14781
  • Institut für Pharmakologie und Klinische Pharmakologie
    Universitätsstr. 1
    40225 Düsseldorf

  • Özlem Gül
  • +49 211 81-12507
  • +49 211 81-14781
  • Institut für Pharmakologie und Klinische Pharmakologie
    Universitätsstr. 1

Responsible for the content: